Oreste
Gualillo
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (11)
2024
-
Adipokines as potential pharmacological targets for immune inflammatory rheumatic diseases: Focus on rheumatoid arthritis, osteoarthritis, and intervertebral disc degeneration
Pharmacological Research, Vol. 205
-
Human recombinant relaxin-2 (serelaxin) regulates the proteome, lipidome, lipid metabolism and inflammatory profile of rat visceral adipose tissue
Biochemical Pharmacology, Vol. 223
2023
2022
-
Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases
Journal of Personalized Medicine, Vol. 12, Núm. 7
-
Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models
International Journal of Molecular Sciences, Vol. 23, Núm. 10
-
The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile
Frontiers in Pharmacology, Vol. 13
2021
-
Relaxin has beneficial effects on liver lipidome and metabolic enzymes
FASEB Journal, Vol. 35, Núm. 7
2020
-
Adipokines and inflammation: Focus on cardiovascular diseases
International Journal of Molecular Sciences, Vol. 21, Núm. 20, pp. 1-34
2019
2018
-
Relaxin activates AMPK-AKT signaling and increases glucose uptake by cultured cardiomyocytes
Endocrine, Vol. 60, Núm. 1, pp. 103-111
2013
-
Ghrelin requires p53 to stimulate lipid storage in fat and liver
Endocrinology, Vol. 154, Núm. 10, pp. 3671-3679